MedTrace Logo

Deproteinised Calf Blood Serum Injection for the Treatment of Acute Intracerebral Hemorrhage

NCT03260153 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-29

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of Deproteinised Calf Blood Serum Injection in alleviating perihematomal edema (PHE) and secondary brain injury, as well as neurologic deficits in patients with acute intracerebral hemorrhage (ICH).

Conditions

  • Intracerebral Hemorrhage

Interventions

DRUG

Deproteinised Calf Blood Serum Injection

DRUG

Placebo (Sodium Chloride)

Sponsors & Collaborators

  • Beijing Stroke Association

    collaborator UNKNOWN

  • Beijing Tiantan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03260153 on ClinicalTrials.gov